175 related articles for article (PubMed ID: 10961590)
1. Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.
Irvine EJ; Greenberg GR; Feagan BG; Martin F; Sutherland LR; Thomson AB; Nilsson LG; Persson T
Inflamm Bowel Dis; 2000 Aug; 6(3):181-7. PubMed ID: 10961590
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of oral budesonide in Japanese patients with active Crohn's disease: a multicentre, double-blind, randomized, parallel-group Phase II study.
Suzuki Y; Motoya S; Takazoe M; Kosaka T; Date M; Nii M; Hibi T
J Crohns Colitis; 2013 Apr; 7(3):239-47. PubMed ID: 22766525
[TBL] [Abstract][Full Text] [Related]
3. Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States.
Tremaine WJ; Hanauer SB; Katz S; Winston BD; Levine JG; Persson T; Persson A;
Am J Gastroenterol; 2002 Jul; 97(7):1748-54. PubMed ID: 12135030
[TBL] [Abstract][Full Text] [Related]
4. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group.
Ewe K; Böttger T; Buhr HJ; Ecker KW; Otto HF
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):277-82. PubMed ID: 10333200
[TBL] [Abstract][Full Text] [Related]
5. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
6. Treatment of joint pain in Crohn's patients with budesonide controlled ileal release.
Florin TH; Graffner H; Nilsson LG; Persson T
Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):295-8. PubMed ID: 10779128
[TBL] [Abstract][Full Text] [Related]
7. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group.
Irvine EJ; Feagan B; Rochon J; Archambault A; Fedorak RN; Groll A; Kinnear D; Saibil F; McDonald JW
Gastroenterology; 1994 Feb; 106(2):287-96. PubMed ID: 8299896
[TBL] [Abstract][Full Text] [Related]
8. Oral budesonide as maintenance therapy in Crohn's disease--results of a 12-month study. Global Budesonide Study Group.
Ferguson A; Campieri M; Doe W; Persson T; Nygård G
Aliment Pharmacol Ther; 1998 Feb; 12(2):175-83. PubMed ID: 9692692
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules.
Green JR; Lobo AJ; Giaffer M; Travis S; Watkins HC;
Aliment Pharmacol Ther; 2001 Sep; 15(9):1331-41. PubMed ID: 11552903
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization.
Herfarth H; Gross V; Andus T; Caesar I; Vogelsang H; Adler G; Malchow H; Petri A; Gierend M; Schölmerich J;
Int J Colorectal Dis; 2004 Mar; 19(2):147-52. PubMed ID: 13680283
[TBL] [Abstract][Full Text] [Related]
11. Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.
Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E;
Am J Gastroenterol; 2002 Mar; 97(3):649-53. PubMed ID: 11922560
[TBL] [Abstract][Full Text] [Related]
12. Enteric-coated budesonide for the induction and maintenance of remission of Crohn's disease in children.
Cohen SA; Aloi M; Arumugam R; Baker R; Bax K; Kierkuś J; Koletzko S; Lionetti P; Persson T; Eklund S
Curr Med Res Opin; 2017 Jul; 33(7):1261-1268. PubMed ID: 28420280
[TBL] [Abstract][Full Text] [Related]
13. Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index.
Thia K; Faubion WA; Loftus EV; Persson T; Persson A; Sandborn WJ
Inflamm Bowel Dis; 2011 Jan; 17(1):105-11. PubMed ID: 20629100
[TBL] [Abstract][Full Text] [Related]
14. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
[TBL] [Abstract][Full Text] [Related]
15. Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
Loftus EV; Feagan BG; Colombel JF; Rubin DT; Wu EQ; Yu AP; Pollack PF; Chao J; Mulani P
Am J Gastroenterol; 2008 Dec; 103(12):3132-41. PubMed ID: 18853973
[TBL] [Abstract][Full Text] [Related]
16. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group.
Greenberg GR; Feagan BG; Martin F; Sutherland LR; Thomson AB; Williams CN; Nilsson LG; Persson T
Gastroenterology; 1996 Jan; 110(1):45-51. PubMed ID: 8536887
[TBL] [Abstract][Full Text] [Related]
17. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.
Irvine EJ; Zhou Q; Thompson AK
Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664
[TBL] [Abstract][Full Text] [Related]
18. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P
Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634
[TBL] [Abstract][Full Text] [Related]
19. Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.
Greenberg GR; Feagan BG; Martin F; Sutherland LR; Thomson AB; Williams CN; Nilsson LG; Persson T
N Engl J Med; 1994 Sep; 331(13):836-41. PubMed ID: 8078529
[TBL] [Abstract][Full Text] [Related]
20. A comparison of budesonide with prednisolone for active Crohn's disease.
Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
